MDL Judge Won’t Keep AndroGel Marketing Out Of Bellwether Retrial

(September 14, 2017, 2:35 PM EDT) -- CHICAGO — An Illinois federal multidistrict litigation judge on Sept. 13 denied a motion by AbbVie Inc. to reconsider his decision allowing certain marketing evidence in a Sept. 18 retrial of an AndroGel heart attack case (In Re:  Testosterone Replacement Therapy Products Liability Litigation, MDL No. 14-1748, N.D. Ill.)....

Related Sections